NCT01625715View on ClinicalTrials.gov

Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization

PHASE2UnknownINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

September 30, 2012

Conditions
Peanut Allergies in Children
Interventions
DRUG

Ketotifen

titrated dose: 1 mg once a day, then 1 mg twice a day then 2 mg twice a day

Trial Locations (1)

M4V 1R2

GSCRI, Toronto

Sponsors
All Listed Sponsors
collaborator

Mast Cell Pharmaceuticals Inc.

INDUSTRY

lead

Gordon Sussman Clinical Research

OTHER